LONDON, February 2, 2018 /PRNewswire/ --
Contract Detailing, Contract Non-Personal Promotion, Medical Education Services, Sample Management Services, Teledetailing Services, Edetailing Services
Report Details
The global pharma contract sales market is expected to grow at a CAGR of 9.6% in the first half of the forecast period. The market is expected to grow at a CAGR of 7.9% from 2017-2028. The market is estimated at $5.48bn in 2017 and $9.48bn in 2023.
(Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 238-page report you will receive 88 tables and 64 figures- all unavailable elsewhere.
The 238-page report provides clear detailed insight into the global pharma contract sales market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Global Pharma Contract Sales Market forecasts from 2018-2028
• Along with revenue prediction for the overall world market for pharma contract sales market, our investigation shows forecasts to 2028 for the following submarkets:
- Contract detailing (personal promotion/field sales)
- Contract non-personal promotion, with further sub-forecasting for teledetailing, eDetailing and others
- Medical education services
- Sample management services
• This report also breaks down the revenue forecast for pharma contract sales market by therapeutic segments:
- Cardiovascular disease
- Metabolic disorders
- Cancer treatment
- Other
• This report provides individual revenue forecasts to 2028 for these regional and national markets:
- USA
- Japan
- Germany, UK, France, Italy and Spain (EU5 countries)
- China, India, Brazil and Russia (BRIC group)
• Our study discusses the SWOT and STEP factors of the global pharma contract sales market
• Our study discusses issues affecting the pharma contract sales industry and market from 2017:
- Outsourced and in-house sales reps - trends and emerging sales models, including multiple channels (multichannel marketing to medical professionals)
- Services CSOs offer and benefits to drug companies outsourcing medical sales
- Maturing brands and product launches, including flexibility in field sales teams
- Legislation and new market access requirements for pharma sales representatives
- Changes to online marketing and potential for IT technologies Risk-sharing agreements
- Key account management (KAM) and medical science liaison (MSL)
• This report discusses the leading companies in pharma contract sales
Visiongain's study is intended for anyone requiring commercial analyses for the global pharma contract sales market. You find data, trends and predictions.
Buy our report today Global Pharma Contract Sales Market 2018-2028: Contract Detailing, Contract Non-Personal Promotion, Medical Education Services, Sample Management Services, Teledetailing Services, Edetailing Services.
To request a report overview of this report please contact Sara Peerun at sara.peerun@visiongain.com (+44-(0)-20-7336-6100) or refer to our website: https://www.visiongain.com/Report/2115/Global-Pharma-Contract-Sales-Market-2018-2028
Leading Companies and Organisations Mentioned
AbbVie
Actavis
Actelion Pharmaceuticals
Addison Whitney
Adheris Health
Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM)
Agência Nacional de Vigilância Sanitária (ANVISA)
Akrikhin
Alexion
Allergan
Amgen
Apple
Aquilant Specialist Healthcare Services
Arbor Pharmaceuticals Ireland
Arena Pharmaceuticals
Ashfield Commercial and Medical Services
Association of the British Pharmaceutical Industry (ABPI)
AstraZeneca
Bayer Healthcare
Biogaran
Biogaran
Boehringer Ingelheim
Brazilian Ministério da Saúde (Ministry of Health)
Bristol Myers Squibb
Cegedim
Celesio
Celgene
Centers of Medicare and Medicaid Services (CMS)
Chinese Ministry of Health
CMIC
Daiichi Sankyo
Dayarn Pharma
Dendreon
Depomed
DottNet.it
Drug Safety Alliance (DSA)
Eisai
Eli Lilly and Co.
Encore Health Resources
Endo Pharmaceuticals
European Commission (EC)
European Federation of Pharmaceutical Industries and Associations (EFPIA)
European Medicines Agency (EMA)
European Promotional Product Association (EPPA)
Expansis
Food and Drugs Administration (FDA)
Galliard
German FSA
Gesamtverband der Werbeartikel Wirtschaft e.V. (GWW)
Go! Healthcare Marketing
Gralise
Group DCA
GSK
Haymarket Media
Hospira
In2Focus
Innovex
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesenis (IQWiG)
International Federation of Pharmaceutical Manufacturers & Associations
Interpace BioPharma
inVentiv Health
Invida
J. Knipper and Company
Janssen Biotech
Japanese Pharmaceutical Manufacturers Association (JPMA)
Kadrige
Kare Pharma International
Knowledge Point360
L'Agenzia Italiana del Farmaco (AIFA)
Liberty Lane Partners
Lupin
Marvecs
Medical Communications Group (MCG)
Medical Council of India (MCI)
MediMedia Health
Menarini Asia-Pacific
Merck & Co.
Merqurio Pharma
Merrimack
Millennium Pharmaceuticals
Ministère des Affaires Sociales et de la Santé
National Health Service (NHS)
National Institute for Health and Care Excellence (NICE)
Navicor
Neurocrine Biosciences
Neurocrine Biosciences.
NovaMed
Novartis
Novella Clinical
Novo Nordisk
OnCall LLC
Organization of Pharmaceutical Producers of India (OPPI)
Otsuka
PALIO
PDI
Pharmaceutical Research and Manufacturers of America (PhRMA)
Pharmagistics
Pharmexx
Polpharma
Promius Pharma
Publicis Healthcare Communications Group
Publicis Touchpoint
Qforma
Quantia
QuintilesIMS
Ramco Import Export
Roche
Salesforce.com
Sanofi
Schering-Plough
Sermo
Sharp Packaging Services
Sinclair IS Pharma
Smithkline Beecham
Sofip (Société de Franchise pour l'Information Pharmaceutique)
StayinFront
Symplmed Pharmaceuticals
Synopia Rx
Taiho Oncology
Takeda
Tardis Medical
Temasek Holdings
Tesaro
Teva Pharmaceutical Industries
The Dartmouth Institute for Health Policy and Clinical Practice
The Medicines Company
The Organization of Pharmaceutical Producers of India (OPPI)
Thomas H. Lee Partners
Transgenomic
UDG Healthcare
UK Department of Health
United Therapeutics
Univadis
US Center for Disease Prevention and Control (CDC)
US Congressional Budget Office (CBO)
US Supreme Court
Veeva Systems
Vivus
World Health Organisation (WHO)
ZS Associates
Zuellig Pharma
To see a report overview please email Sara Peerun on sara.peerun@visiongain.com
Share this article